Regeneron Pharmaceuticals (REGN.VI) Q2 2025 Earnings

29AprConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
7.22
8.69
10.16
11.64

Details

Expected EPS
7.568659607759999
Actual EPS
7.2160092
Surprise EPS
-0.35
Surprise Percent
+4.66%

Description

Regeneron Pharmaceuticals (REGN.VI) has reported earnings of 7.2160092 per share for Q2 2025.

0 Comments

Share your thoughts